Does Duloxetine Improve Cognitive Function Independently of Its Antidepressant Effect in Patients with Major Depressive Disorder and Subjective Reports of Cognitive Dysfunction?

Introduction. Cognitive deficits are commonly reported by patients with major depressive disorder (MDD). Duloxetine, a dual serotonin/noradrenaline reuptake inhibitor, may improve cognitive deficits in MDD. It is unclear if cognitive improvements occur independently of antidepressant effects with st...

Descripción completa

Detalles Bibliográficos
Autores principales: Greer, Tracy L., Sunderajan, Prabha, Grannemann, Bruce D., Kurian, Benji T., Trivedi, Madhukar H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915915/
https://www.ncbi.nlm.nih.gov/pubmed/24563781
http://dx.doi.org/10.1155/2014/627863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915915/
https://www.ncbi.nlm.nih.gov/pubmed/24563781
http://dx.doi.org/10.1155/2014/627863

Ejemplares similares